Abstract
In the pharmaceutical industry, cell culture is a major foundation of
biopharmaceutical development, bioprocessing and manufacturing.
Biopharmaceutical products are developed from large, complex protein
molecules, which require equally complex manufacturing methods and an array of
analytical techniques. As growing cells for biopharmaceutical production is
slow, expensive and complicated, optimizing cell culture development is of
paramount concern to companies developing biopharmaceuticals.
This report is focused on cell culture used in the research and production of
biopharmaceuticals, analyzing the world cell culture market and the major
trends driving this market in three specific segments:
- Media,
- Sera, and
- Reagents
In addition to a thorough discussion of the technologies and techniques
currently employed and emerging in the cell culture area, the report provides
specific information on
- Market size and growth through 2011
- Competitive market share of leading suppliers
- Details on recent M&A activities
- Profiles of 28 leading players in the market
- Examination of the trends in animal-free and chemically defined products.
The information for this report was gathered using both primary and secondary
research including comprehensive research of secondary sources such as company
literature, databases, investment reports, and medical and business journals.
Telephone interviews and email correspondence were the primary method of
gathering information. For the purpose of this study Kalorama Information
conducted interviews with key industry officials, consultants, and government
personnel. These sources were the primary basis in gathering information
specifically relating to revenue and market share data presented in this
report. Specific interviews with pharmaceutical company and cell culture
supply company representatives included marketing directors, division
managers, and product representatives.
View Cart
